SCHEMBL2352062

SCHEMBL2352062

Fc1ccc(-n2c(Cl)cc3ccccc32)cc1Cl

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ RXFP1 Q9HBX9 2/20 0.43
▸ HTT P42858 2/20 0.43
▸ NPSR1 Q6W5P4 1/20 0.43
▸ PHOSPHO1 Q8TCT1 1/20 0.40
▸ BRD9 Q9H8M2 2/20 0.40
▸ KDR P35968 3/20 0.39
▸ PDGFRB P09619 1/20 0.39
▸ KAT2B Q92831 2/20 0.39
▸ PIN1 Q13526 1/20 0.39
▸ MET P08581 1/20 0.39
▸ MEN1 O00255 1/20 0.38
▸ GAA P10253 1/20 0.38
▸ KMT2A Q03164 1/20 0.38
▸ MAPT P10636 1/20 0.38
▸ ALDH1A1 P00352 1/20 0.38
▸ PKM P14618 1/20 0.38
▸ PIK3CA P42336 1/20 0.38
▸ IDO1 P14902 1/20 0.37
▸ TDO2 P48775 1/20 0.37
▸ ABCG2 Q9UNQ0 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28278239 0.81 CYP19A1 (0.48) METMEN1KMT2AMAPTALDH1A1
SCHEMBL11557771 0.77 ALDH1A1 (0.55) HTTMEN1GAAKMT2AALDH1A1
SCHEMBL2343308 0.76 SOS1 (0.47) RXFP1HTTNPSR1ABCG2
SCHEMBL16237984 0.71 PHOSPHO1 (0.44) RXFP1HTTNPSR1PHOSPHO1BRD9
SCHEMBL28365059 0.69 MDM2 (0.40) RXFP1METMAPTALDH1A1
SCHEMBL27651991 0.68 PHOSPHO1 (0.44) RXFP1HTTNPSR1PHOSPHO1BRD9
SCHEMBL29864897 0.68 BRD9 (0.42) RXFP1HTTNPSR1PHOSPHO1BRD9
SCHEMBL6107660 0.66 KMT2A (0.58) KDRPDGFRBMEN1KMT2AMAPT
SCHEMBL28369134 0.65 BIRC5 (0.44) HTTNPSR1GAAMAPTALDH1A1
SCHEMBL30417152 0.64 KMT2A (0.38) MEN1KMT2AMAPTALDH1A1BIRC5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8008491-B2 poly(adenosine 5'-diphosphate ribose) polymerase inhibitors such as 1-phenyl-2-(piperazin-1-yl)-1,3-dihydropyrrolo[2,3-b]pyridine-3-carboxaldehyde, used in the treatment and/or prevention central nervous system and cardiovascular disorders AVENTIS PHARMACEUTICALS, INC. (US) 2011-08-30 — — US disclosed
Send feedback